This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Dominique Janssens
Introduction
Dominique Janssens is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of biotechnology, particularly in the culturing of bacteria. His work has implications for various applications in the pharmaceutical and biological industries.
Latest Patents
Janssens holds a patent for the "Fermentation of fastidious bacterial strain in perfusion suspension culture." This invention relates to improved processes for culturing bacteria, specifically focusing on perfusion suspension culturing in a fermenter. The process involves circulating the culture medium, which includes the bacteria, over a separation system in alternating tangential flow. This innovative separation system effectively removes a filtrate containing inhibitory metabolites from the culture medium, enhancing the efficiency of bacterial growth.
Career Highlights
Dominique Janssens is associated with GlaxoSmithKline Biologicals SA, a leading company in the field of vaccines and biologics. His work at this organization has allowed him to contribute to advancements in bacterial fermentation processes, which are crucial for the development of various biological products.
Collaborations
Throughout his career, Janssens has collaborated with several esteemed colleagues, including Philippe Marc, Helene Dehottay, and Michael Lanero Fidalgo. These collaborations have fostered a productive environment for innovation and research in the field of biotechnology.
Conclusion
Dominique Janssens exemplifies the spirit of innovation in biotechnology through his patent and contributions to bacterial culturing processes. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
